CLINICAL AND GENETIC FEATURES OF THE DEVELOPMENT OF METABOLIC AND CARDIORENAL SYNDROME IN PATIENTS WITH GOUT

The article highlights the development of metabolic and cardiorenal disorders in patients with gout, their clinical characteristics, and their relationship with genetic predisposition. The significance of hyperuricemia, inflammatory processes, and impaired internal organ function in the development of gout-related complications is discussed. Particular attention is paid to the potential role of genetic factors and the improvement of individualized approaches to patient management.